PMID- 28750075 OWN - NLM STAT- MEDLINE DCOM- 20171009 LR - 20211204 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 7 DP - 2017 TI - CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway. PG - e0181866 LID - 10.1371/journal.pone.0181866 [doi] LID - e0181866 AB - Cultivating an environment of mutualism between host cells and the microbiota is vital, and dysregulation of this relationship is associated with multiple immune disorders including metabolic and skin diseases, asthma, allergy, and Inflammatory Bowel Disease (IBD). One prominent mechanism for maintaining homeostasis is the protective regulatory T cell (Treg)- Immunoglobulin A (IgA) pathway toward microbiota antigens, in which Tregs maintain homeostasis and provide critical survival factors to IgA+ B cells. In order to amplify the Treg-IgA pathway, we have generated a fusion protein, CBirTox, comprised of a portion of the carboxy terminus of CBir1, a microbiota flagellin, genetically coupled to Cholera Toxin B subunit (CTB) via the A2 linker of CT. Both dendritic cells (DCs) and B cells pulsed with CBirTox selectively induced functional CD4+Foxp3+ Tregs in vitro, and CBirTox augmented CD4+Foxp3+ cell numbers in vivo. The induced Foxp3 expression was independent of retinoic acid (RA) signaling but was inhibited by neutralization of TGF-beta. CBirTox treatment of B cells downregulated mammalian target of rapamycin (mTOR) signaling. Furthermore, CBirTox-pulsed DCs induced substantial production of IgA from naive B cells. Collectively these data demonstrate that CBirTox represents a novel approach to bolstering the Treg-IgA pathway at the host-microbiota interface. FAU - Alexander, Katie L AU - Alexander KL AD - Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America. FAU - Katz, Jannet AU - Katz J AD - Department of Pediatric Dentistry, University of Alabama at Birmingham, Birmingham, AL, United States of America. FAU - Elson, Charles O AU - Elson CO AUID- ORCID: 0000-0001-8873-1534 AD - Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States of America. AD - Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United States of America. LA - eng GR - P01 DK071176/DK/NIDDK NIH HHS/United States PT - Journal Article DEP - 20170727 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (CBir1 flagellin) RN - 0 (Epitopes) RN - 0 (Forkhead Transcription Factors) RN - 0 (Foxp3 protein, mouse) RN - 0 (Immunoglobulin A) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Transforming Growth Factor beta) RN - 12777-81-0 (Flagellin) RN - 5688UTC01R (Tretinoin) RN - 9012-63-9 (Cholera Toxin) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Antigen-Presenting Cells/metabolism MH - B-Lymphocytes/immunology MH - Cell Line MH - Cholera Toxin/metabolism MH - Dendritic Cells/immunology MH - Epitopes/*immunology MH - Flagellin/*agonists MH - Forkhead Transcription Factors/metabolism MH - Genomics MH - *Homeostasis MH - Immunoglobulin A/*immunology MH - Intestines MH - Mice, Inbred C57BL MH - *Microbiota MH - Recombinant Fusion Proteins/metabolism MH - Signal Transduction MH - T-Lymphocytes, Regulatory/*immunology MH - TOR Serine-Threonine Kinases/metabolism MH - Transforming Growth Factor beta/metabolism MH - Tretinoin/metabolism PMC - PMC5531474 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2017/07/28 06:00 MHDA- 2017/10/11 06:00 PMCR- 2017/07/27 CRDT- 2017/07/28 06:00 PHST- 2017/03/01 00:00 [received] PHST- 2017/07/07 00:00 [accepted] PHST- 2017/07/28 06:00 [entrez] PHST- 2017/07/28 06:00 [pubmed] PHST- 2017/10/11 06:00 [medline] PHST- 2017/07/27 00:00 [pmc-release] AID - PONE-D-17-08245 [pii] AID - 10.1371/journal.pone.0181866 [doi] PST - epublish SO - PLoS One. 2017 Jul 27;12(7):e0181866. doi: 10.1371/journal.pone.0181866. eCollection 2017.